Healthcare101

 The global IV equipment market is projected to reach USD 23.92 billion by 2031 from USD 17.82 billion in 2026, growing at a CAGR of 6.1% during the forecast period. The IV equipment market is expected to grow significantly, driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population. The demand for safe and reliable devices is driven by the growing use of IV therapy across hospitals, clinics, and home care settings. The introduction of needle-free connectors and smart infusion systems, together with advancements in the healthcare infrastructure in developing countries, is contributing to the enhanced growth of the market. Browse 400 market data Tables and 65 Figures spread through 400 Pages and in-depth TOC on “IV Equipment Market — Global Forecast to 2031” IV Equipment Market Trends & Insights: The IV catheters segment accounted for the largest share of 37.0% of the market in 2025. The medication administration segment accounted for the la...

 The world of biotechnology has witnessed a revolutionary breakthrough with the discovery of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). This powerful gene-editing technology has redefined how scientists manipulate DNA, offering unprecedented precision, efficiency, and affordability. From curing genetic disorders to improving crop resilience, CRISPR is shaping the future across multiple industries. What is CRISPR and How Does It Work? CRISPR is a natural defense mechanism found in bacteria that scientists have adapted for gene editing. It works alongside the Cas9 enzyme—often referred to as “molecular scissors”—to cut DNA at a specific location. Once the DNA is cut, scientists can remove, add, or modify genetic material. The breakthrough work of Jennifer Doudna and Emmanuelle Charpentier led to the development of CRISPR-Cas9 as a programmable gene-editing tool, earning them the Nobel Prize in Chemistry in 2020. Download PDF Brochure Key Components:...

 The global Tissue Diagnostics market , valued at USD 6.19 billion in 2024, stood at USD 6.74 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of USD 10.86 billion by the end of the period. The market growth is driven by the rising incidence of cancer and the growing demand for digital pathology , which are fueling the need for more accurate and high-throughput tissue-based diagnostics.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949 Tissue Diagnostics Market Trends & Insights: The tissue diagnostics market is segmented into immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, special staining, and other technologies, with IHC leading the market. The tissue diagnostics market is segmented into consumables, instruments, software, and services, with consumables accounting for the largest share. The tissue diagnostics market is segme...

 The global peptide synthesis market is estimated to expand to a value of USD 1.44 billion in 2029 from USD 0.91 billion in 2024, growing at a CAGR of 9.5%. The rise in biopharmaceutical research and the use of synthetic peptides in vaccine development, such as mRNA vaccines, is likely to fuel market growth. The outsourcing trend for peptide synthesis services by pharmaceutical companies to reduce costs and focus on core competencies is further likely to support market expansion. Download PDF Brochure The products segment accounted for the largest share of the offerings segment in the peptide synthesis market in 2023. Based on offerings, the market is segmented into products and services. By-products market is further divided into consumables and instruments. Among these consumables dominated the peptide synthesis market. The consumables segment is further bifurcated into reagents and other consumables. The reagents market is further divided into resins, amino acids, coupling reag...

 The global Patient Engagement Solutions Market is undergoing a major transformation as healthcare systems increasingly embrace digital health and patient-centered technologies. According to the latest MarketsandMarkets report, the market is projected to reach USD 41.8 billion by 2028 , up from USD 22.5 billion in 2023 , growing at a CAGR of 13.2% during the forecast period. This strong growth reflects a global shift toward value-based care , increased government support for healthcare digitalization , and the widespread adoption of mobile health (mHealth) applications . Download PDF Brochure 🩺 What’s Driving the Market Growth? The rapid expansion of the patient engagement solutions market can be attributed to several key factors: Rising Collaborations and Partnerships: Healthcare providers, technology companies, and payers are forming strategic alliances to create integrated platforms that improve communication and care coordination. Government ...

  Market Overview The global injection pen market is a significant segment within the broader drug delivery systems industry. Injection pens are prefilled or reusable devices designed for self-administration of medication, offering convenience, accuracy, and ease of use compared to traditional syringes. These devices are particularly popular among patients with chronic conditions requiring regular injections, such as diabetes, rheumatoid arthritis, and growth hormone deficiencies. Download PDF Brochure Market Forecast and Growth Projections The global injection pen market, valued at US$43.8 billion in 2023, stood at US$47.0 billion in 2025 and is projected to advance at a resilient CAGR of 7.9% from 2024 to 2030, culminating in a forecasted valuation of US$74.1 billion by the end of the period.  Key Growth Drivers Several factors are contributing to the anticipated growth of the injection pen market: Rising Prevalence of Chronic Diseases: The increasing...